| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |